EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Anti-Metastatic Properties of Glutathione-Stabilized Gold Nanoparticles—A Preliminary Study on Canine Osteosarcoma Cell Lines

Sylwia S Wilk, Klaudia I Kukier, Arkadiusz M Michałowski iD, Marek Wojnicki iD, Bartosz Smereczyński, Michał Wójcik iD, Katarzyna A Zabielska-Koczywąs iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sylwia S Wilk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental and Clinical NanoOncology, Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw Univer…. Hauptthemen laut MEDLINE: Gold, Osteosarcoma, Metal Nanoparticles, Glutathione. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doctoral School of the Warsaw University of Life Sciences—SGGW, Science Development Fund of the Warsaw University of Life Sciences—SGGW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OSA) is the most common primary bone malignancy in dogs, characterized by aggressive growth and high metastatic potential. Despite advances in treatment, the prognosis for affected animals remains poor, mainly due to metastatic disease. Metastasis is a complex process that involves forming new blood vessels in the primary tumor (angiogenesis), intravasation, the transport of cancer cells to other locations, extravasation, and the growth of cancer cells in the secondary site. Gold nanoparticles (AuNPs), due to their unique physicochemical properties, are considered promising tools in cancer therapy, both as drug delivery systems and potential anti-metastatic agents. Previously, it has been demonstrated that 500 µg/mL glutathione-stabilized gold nanoparticles (Au-GSH NPs) inhibit cancer cell extravasation—one of the steps of the metastatic cascade. This study aimed to evaluate the anti-metastatic properties of Au-GSH NPs through their influence on OSA cell migration, proliferation, and colony formation in vitro, as well as their antiangiogenic properties on the chick embryo chorioallantoic (CAM) model. Additionally, we investigated whether these effects are associated with changes in alpha-2-macroglobulin (A2M) expression, as it was previously demonstrated to play an essential role in the metastatic cascade. Au-GSH NPs significantly inhibited migration and colony formation in canine osteosarcoma cells (from OSCA-8, OSCA-32, and D-17 cell lines) at 200 µg/mL concentrations. Interestingly, at 500 µg/mL, Au-GSH NPs inhibited angiogenesis on the CAM model and cancer cell migration, but fewer colonies were formed. These results may be directly related to the higher efficiency of Au-GSH NPs uptake by OSA cells at the dose of 200 μg/mL than at the dose of 500 μg/mL, as demonstrated using Microwave Plasma Atomic Emission Spectroscopy (MP-AES). Moreover, this is the first study that demonstrates a significant increase in A2M expression in cancer cells after Au-GSH NPs treatment. This study provides new insight into the potential use of Au-GSH NPs as anti-metastatic agents in canine osteosarcoma, indicating that their anti-metastatic properties may be related to A2M. However, further in vitro and in vivo studies are needed to explore the molecular mechanism underlying these effects and to evaluate the clinical relevance of AuNPs in veterinary oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldOsteosarcomaMetal NanoparticlesGlutathioneBone NeoplasmsAntineoplastic AgentsAnimalsDogsCell Line, TumorCell MovementCell ProliferationChick EmbryoNeoplasm Metastasis

Stichwörter der Autor:innen

Simple Westernalpha 2 macroglobulincanine osteosarcomagold nanoparticlesmetastasismigration

Substanzen

GoldGlutathioneAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratory of Experimental and Clinical NanoOncology, Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland.
  • Faculty of Non-Ferrous Metals, AGH University of Krakow, Al. A. Mickiewicza 30, 30-059 Kraków, Poland.
  • Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.

ORCID-Profile: Arkadiusz M Michałowski, Marek Wojnicki, Michał Wójcik, Katarzyna A Zabielska-Koczywąs

Förderung

  • Doctoral School of the Warsaw University of Life Sciences—SGGW
  • Science Development Fund of the Warsaw University of Life Sciences—SGGW

Zitieren

APA

Wilk, S. S., Kukier, K. I., Michałowski, A. M., Wojnicki, M., Smereczyński, B., Wójcik, M., & Zabielska-Koczywąs, K. A. (2025). The Anti-Metastatic Properties of Glutathione-Stabilized Gold Nanoparticles—A Preliminary Study on Canine Osteosarcoma Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136102

Vancouver

Wilk SS, Kukier KI, Michałowski AM, Wojnicki M, Smereczyński B, Wójcik M, et al. The Anti-Metastatic Properties of Glutathione-Stabilized Gold Nanoparticles—A Preliminary Study on Canine Osteosarcoma Cell Lines. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136102

BibTeX
@article{Wilk2025,
  author = {Wilk, Sylwia S and Kukier, Klaudia I and Michałowski, Arkadiusz M and Wojnicki, Marek and Smereczyński, Bartosz and Wójcik, Michał and Zabielska-Koczywąs, Katarzyna A},
  title = {The Anti-Metastatic Properties of Glutathione-Stabilized Gold Nanoparticles—A Preliminary Study on Canine Osteosarcoma Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136102}
}
Kostenlos starten →